Press
Dr. Sarah Hawley, Maisel Research Professorship naming in 2023.
Dr. Megan Haymart, Nancy Wigginton Endocrinology Research Professorship naming in 2019.
Brandon Moretti appointed as trainee observer to the ATA Board of Directors (2023-2024).
Debbie Chen, notice of Outstanding Abstract Award for ENDO 2023 in Chicago, IL, "Real World Use of Systemic Therapy for Treatment of Advanced Thyroid Cancer.
Maria Papaleontiou to help revise hypothyroidism guidelines for American Thyroid Association.
Maria Papaleontiou serving as chair of the ATA Women in Thyroidology 2022-2023.
Megan Haymart, presented the Annual Sidney H. Ingbar Lectureship Virtual Medical Grand Rounds on October 13 2022 at Beth Israel Deaconess Medical Center in Boston, Massachusetts, “Thyroid Cancer Management: How can we do better?”.
Megan Haymart, 2nd woman in 32 years to give the Cedars-Sinai Boris Catz lecture to the Department of Internal Medicine, on September 23 2022 in Los Angeles, California, "Questioning Thyroid Cancer Management: How can we do more?".
2022 Sandy-Hassmiller Early Career Health Services Research Award Recipient, Dr. Debbie Chen, study titled "Real-World Use of Systemic Therapies for Patients with Advanced Thyroid Cancer".
Mousumi Banerjee, University of Michigan Precision Health Member Spotlight
Maria Papaleontiou, "Keeping Thyroid Hormone Treatment On Target Is Key for the Heart" More press on this topic HERE.
2021 Woman of the Year Award, selected by the Women in Thyroidology of the American Thyroid Association, given to recognize the outstanding contributions of a woman in thyroidology who has demonstrated a long-standing commitment to the ATA and the advancement of women both within the organization and in the field, granted to Dr. Megan Haymart.
2021 MICHR Distinguished Clinical and Translational Research Mentor Award Recipient, Dr. Megan Haymart
2021-2022 USDeN Pilot Award Grantee, Dr. Maria Papaleontiou
2021 AACE Award Recipients: Hossein Gharib MD, Educational Lectureship Award
AACE Rising Star in Endocrinology Award Recipient Maria Papaleontiou, MD.
Megan Haymart, "Thyroid Cancer: How much Surveillance is too Much?", ENDO 2021 Faculty Interview.
Megan Haymart, "Clinical context crucial when treating thyroid cancer in older adults"
Megan Haymart, "Choose wisely: Tailor thyroid cancer treatments to minimize harms"
Megan Haymart, "Strategies for surveillance after thyroid cancer ‘cure’ based on treatment type"
Rachel Beeson, "Nearly one-third of older thyroid patients take medications that interfere with thyroid function tests" More press on this topic HERE and HERE.
Debbie Chen, Endocrine Society Outstanding Abstract Award in conjunction with ENDO 2021 for "Unmet Information Needs Among Hispanic Women With Thyroid Cancer".
Thyroid Journal, Special Collection on Thyroid Cancer, Two of our team’s manuscripts are top read thyroid cancer articles. " "Patient Report of Recurrent and Persistent Thyroid Cancer" and "Disparities Research in Thyroid Cancer: Challenges and Strategies for Improvement".
Megan Haymart, "Many Thyroid Cancer Ultrasound Scans Unnecessary" More press on this topic HERE.
Behind the Scenes- Dr. Maria Papaleontiou
Behind the Scenes- Dr. Megan Haymart
Maria Papaleontiou, "Is Thyroid Cancer a "Good Cancer?"
Maria Papaleontiou, Endocrine Society Press Release: Survey finds physicians struggle to communicate positive prognosis to thyroid cancer patients. See the full virtual news conference HERE.
Maria Papaleontiou, Thyroid Hormone replacement increased and risk of stroke. More press on this topic HERE
Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance, Cancer, Josh Evron, MD. More press on this topic HERE and HERE.
Debbie Chen, abstract titled "Disparities in the overestimation of thyroid cancer risk of recurrence and death" selected as one of the thirty (32) 2019 Trainee Poster Contest finalists and having one of the top scoring trainee abstracts for ATA 2019.
Voice Abnormalities Prevalent After Thyroid Surgery, JAMA Oto, Kevin Kovatch, MD
Megan Haymart, interview on "Voice Changes Common After Thyroid Surgery".
Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?, JCO, Lauren Wallner, PhD
More press on this topic HERE and HERE
Fracture Risk in Men With Thyroid Cancer, Oncologist, Maria Papaleontiou, MD
Low-risk thyroid cancer diagnoses increasing as ultrasound use rises. Megan R. Haymart, MD
The Michigan Otolaryngological Society 2018 Resident Recognition Award Program Results. First Place: The 2018 Walter M. Belenky, M.D., Resident Research Award Winner, Kevin J. Kovatch, M.D. - “Abnormal Voice and Vocal Fold Motion Impairment Following Surgery for Thyroid Cancer”
Thyroid surgery complications more common than previously believed, JCEM, Maria Papaleontiou and More press on this topic HERE
Video Interview with Dr. Megan Haymart and Dr. Mousumi Banerjee, BMJ
The Endocrine Society, ENDO 2016, Megan Haymart
The Endocrine Society News, Maria Papaleontiou
PET imaging used in about 20% of differentiated thyroid cancers, Jaime Wiebel
Researchers assess radioactive iodine use in medium-risk thyroid cancer, Megan Haymart
2015 McDevitt Excellence in Research Award from BCBSM
Clinical Endocrinology News, Jaime Wiebel
JCEM Press- Featured Author (February 2014), Nazanene Esfandiari
